(Q39321330)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18394125%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

title

Carbohydrate-based particles reduce allergic inflammation in a mouse model for cat allergy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18394125%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

0 references

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18394125%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Ursula Wiedermann

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18394125%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Hans Grönlund

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18394125%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Marianne van Hage

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18394125%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

T Neimert-Andersson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18394125%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

S Thunberg

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18394125%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

L Swedin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18394125%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

G Jacobsson-Ekman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18394125%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

S-E Dahlén

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18394125%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

A Scheynius

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18394125%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

1 May 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18394125%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18394125%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18394125%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18394125%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

518-526

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18394125%20AND%20SRC:MED&resulttype=core&format=json

Immunological mechanisms of allergen-specific immunotherapy

5 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01644.X

Mechanisms of immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01644.X

(How) do aluminium adjuvants work?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01644.X

Vaccination with genetically engineered allergens prevents progression of allergic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01644.X

Rational design of hypoallergens applied to the major cat allergen Fel d 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01644.X

Induction of interleukin-10 and suppressor of cytokine signalling-3 gene expression following peptide immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01644.X

A chimeric human-cat fusion protein blocks cat-induced allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01644.X

Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01644.X

Carbohydrate-based particles: a new adjuvant for allergen-specific immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01644.X

A novel adjuvant-allergen complex, CBP-rFel d 1, induces up-regulation of CD86 expression and enhances cytokine release by human dendritic cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01644.X

Formation of disulfide bonds and homodimers of the major cat allergen Fel d 1 equivalent to the natural allergen by expression in Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01644.X

Allergenic characterization of Acarus siro and Tyrophagus putrescentiae and their crossreactivity with Lepidoglyphus destructor and Dermatophagoides pteronyssinus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01644.X

Expression of nitric oxide synthase-2 in the lungs decreases airway resistance and responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01644.X

An ELISA for recombinant Lepidoglyphus destructor, Lep d 2, and the monitoring of exposure to dust mite allergens in farming households

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01644.X

Influence of the route of sensitization on local and systemic immune responses in a murine model of type I allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01644.X

Nineteen cases of persistent pruritic nodules and contact allergy to aluminium after injection of commonly used aluminium-adsorbed vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01644.X

Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01644.X

Pathogen recognition and development of particulate vaccines: does size matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01644.X

Healthy immune response to allergens: T regulatory cells and more

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01644.X

Mechanisms of allergen specific immunotherapy--T-cell tolerance and more

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01644.X

Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01644.X